投資有価証券売却益、Impairment LossEL - Chemistry Reportable Segments Member、Minority Interests他2件
- 【期間】
年度 | 投資有価証券売却益 | Impairment LossEL - Chemistry Reportable Segments Member | Minority Interests | Retirement Benefit LiabilityNCLIFRS | 事業譲受による支出 |
---|
2022/12 | - | | - | | - | | - | | -43.7億 | |